
Page#1
The Procter & Gamble Company 37
Consolidated Statements of Earnings
Amounts in millions except per share amounts; Years ended June 30 2018 2017 2016
NET SALES $ 66,832 $ 65,058 $ 65,299
Cost of products sold 34,268 32,535 32,909
Selling, general and administrative expense 18,853 18,568 18,949
OPERATING INCOME 13,711 13,955 13,441
Interest expense 506 465 579
Interest income 247 171 182
Other non-operating income/(expense), net (126) (404) 325
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 13,326 13,257 13,369
Income taxes on continuing operations 3,465 3,063 3,342
NET EARNINGS FROM CONTINUING OPERATIONS 9,861 10,194 10,027
NET EARNINGS FROM DISCONTINUED OPERATIONS — 5,217 577
NET EARNINGS 9,861 15,411 10,604
Less: Net earnings attributable to noncontrolling interests 111 85 96
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 9,750 $ 15,326 $ 10,508
(1)
BASIC NET EARNINGS PER COMMON SHARE: 
Earnings from continuing operations $ 3.75 $ 3.79 $ 3.59
Earnings from discontinued operations — 2.01 0.21
BASIC NET EARNINGS PER COMMON SHARE $ 3.75 $ 5.80 $ 3.80
(1)
DILUTED NET EARNINGS PER COMMON SHARE: 
Earnings from continuing operations $ 3.67 $ 3.69 $ 3.49
Earnings from discontinued operations — 1.90 0.20
DILUTED NET EARNINGS PER COMMON SHARE $ 3.67 $ 5.59 $ 3.69
DIVIDENDS PER COMMON SHARE $ 2.79 $ 2.70 $ 2.66
(1) 
Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & 
Gamble. 
See accompanying Notes to Consolidated Financial Statements. 
Page#2
The Procter & Gamble Company 39
Consolidated Balance Sheets
Amounts in millions; As of June 30 2018 2017
Assets
CURRENT ASSETS
Cash and cash equivalents $ 2,569 $ 5,569
Available-for-sale investment securities 9,281 9,568
Accounts receivable 4,686 4,594
INVENTORIES
Materials and supplies 1,335 1,308
Work in process 588 529
Finished goods 2,815 2,787
Total inventories 4,738 4,624
Prepaid expenses and other current assets 2,046 2,139
TOTAL CURRENT ASSETS 23,320 26,494
PROPERTY, PLANT AND EQUIPMENT, NET 20,600 19,893
GOODWILL 45,175 44,699
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET 23,902 24,187
OTHER NONCURRENT ASSETS 5,313 5,133
TOTAL ASSETS $ 118,310 $ 120,406
Liabilities and Shareholders' Equity
CURRENT LIABILITIES
Accounts payable $ 10,344 $ 9,632
Accrued and other liabilities 7,470 7,024
Debt due within one year 10,423 13,554
TOTAL CURRENT LIABILITIES 28,237 30,210
LONG-TERM DEBT 20,863 18,038
DEFERRED INCOME TAXES 6,163 8,126
OTHER NONCURRENT LIABILITIES 10,164 8,254
TOTAL LIABILITIES 65,427 64,628
SHAREHOLDERS' EQUITY
Convertible Class A preferred stock, stated value $1 per share (600 shares authorized) 967 1,006
Non-Voting Class B preferred stock, stated value $1 per share (200 shares authorized) — —
Common stock, stated value $1 per share (10,000 shares authorized; shares issued:
2018 - 4,009.2, 2017 - 4,009.2) 4,009 4,009
Additional paid-in capital 63,846 63,641
Reserve for ESOP debt retirement (1,204) (1,249)
Accumulated other comprehensive income/(loss) (14,749) (14,632)
Treasury stock, at cost (shares held: 2018 -1,511.2, 2017 - 1,455.9) (99,217) (93,715)
Retained earnings 98,641 96,124
Noncontrolling interest 590 594
TOTAL SHAREHOLDERS' EQUITY 52,883 55,778
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 118,310 $ 120,406
See accompanying Notes to Consolidated Financial Statements. 
Page#3
The Procter & Gamble Company 41
Consolidated Statements of Cash Flows
Amounts in millions; Years ended June 30 2018 2017 2016
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR $ 5,569 $ 7,102 $ 6,836
OPERATING ACTIVITIES
Net earnings 9,861 15,411 10,604
Depreciation and amortization 2,834 2,820 3,078
Loss on early extinguishment of debt 346 543 —
Share-based compensation expense 395 351 335
Deferred income taxes (1,844) (601) (815)
Gain on sale of assets (176) (5,490) (41)
Goodwill and intangible asset impairment charges — — 450
Change in accounts receivable (177) (322) 35
Change in inventories (188) 71 116
Change in accounts payable, accrued and other liabilities 1,385 (149) 1,285
Change in other operating assets and liabilities 2,000 (43) 204
Other 431 162 184
TOTAL OPERATING ACTIVITIES 14,867 12,753 15,435
INVESTING ACTIVITIES
Capital expenditures (3,717) (3,384) (3,314)
Proceeds from asset sales 269 571 432
Acquisitions, net of cash acquired (109) (16) (186)
Purchases of short-term investments (3,909) (4,843) (2,815)
Proceeds from sales and maturities of short-term investments 3,928 1,488 1,354
Pre-divestiture addition of restricted cash related to the Beauty Brands divestiture — (874) (996)
Cash transferred at closing related to the Beauty Brands divestiture — (475) —
Release of restricted cash upon closing of the Beauty Brands divestiture — 1,870 —
Cash transferred in Batteries divestiture — — (143)
Change in other investments 27 (26) 93
TOTAL INVESTING ACTIVITIES (3,511) (5,689) (5,575)
FINANCING ACTIVITIES
Dividends to shareholders (7,310) (7,236) (7,436)
Change in short-term debt (3,437) 2,727 (418)
Additions to long-term debt 5,072 3,603 3,916
(1)
Reductions of long-term debt (2,873) (4,931) (2,213)
Treasury stock purchases (7,004) (5,204) (4,004)
Treasury stock from cash infused in Batteries divestiture — — (1,730)
Impact of stock options and other 1,177 2,473 2,672
TOTAL FINANCING ACTIVITIES (14,375) (8,568) (9,213)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH
EQUIVALENTS 19 (29) (381)
CHANGE IN CASH AND CASH EQUIVALENTS (3,000) (1,533) 266
CASH AND CASH EQUIVALENTS, END OF YEAR $ 2,569 $ 5,569 $ 7,102
SUPPLEMENTAL DISCLOSURE
Cash payments for interest $ 529 $ 518 $ 569
Cash payment for income taxes 2,830 3,714 3,730
(2)
Divestiture of Batteries business in exchange for shares of P&G stock — — 4,213
Divestiture of Beauty business in exchange for shares of P&G stock and assumption of debt — 11,360 —
Assets acquired through non-cash capital leases are immaterial for all periods.
(1)
 Includes early extinguishment of debt costs of $346 and $543 in 2018 and 2017, respectively.
(2)
 Includes $1,730 from cash infused into the Batteries business pursuant to the divestiture agreement (see Note 13).
See accompanying Notes to Consolidated Financial Statements. 